Periodic Reporting for period 2 - EdiGenT (New Prime Editing and non-viral delivery strategies for Gene Therapy)

Genome editing technologies based on CRISPR/Cas systems allow targeted genomic modification with unprecedented precision and have emerged as powerful alternatives to conventional gene therapy approaches for various human diseases, with a series of clinical trials in progress...